The latest research report by Polaris Market Research provides a thorough analysis of a rapidly growing market. It covers all the key market aspects, including Rare Disease Genetic Testing Market share, size, drivers, trends, and major developments. Also, it offers market forecasts at the national, regional, and global levels. An in-depth analysis of market segments, along with an examination of the market performance across major regions and sub-regions, has been included in the study. The report provides insights into strategic developments to help stakeholders devise effective operating strategies.
The report includes a thorough value chain analysis to help readers gain crucial information on the outbound and inbound market logistics. Additionally, a thorough examination of key market participants addressing diverse consumer needs has been provided in the study. It further covers the emerging market trends and opportunities market participants can capitalize on. Pictorial representations, including charts, tables, and graphs, have been provided to help readers comprehend the key stats and other data easily.
According to the research report, the global rare disease genetic testing market was valued at USD 334.7 million in 2023 and is expected to reach USD 3,102.4 million by 2032, to grow at a CAGR of 12.70% during the forecast period.
Market Dynamics:
This section of the research report sheds light on the evolution of the market, covering how market participants are responding to technological shifts. The impact of the shifting market landscape and globalization has been provided in the study. Also, all the key factors driving Rare Disease Genetic Testing market growth have been covered.
The report covers major market trends and opportunities market participants can capitalize on. Additionally, it presents crucial information on market restraints and challenges and how businesses can navigate them. Furthermore, an analysis of technological advancements and regulatory shifts and their impact on market demand has been included in the study.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market
A few of the key players operating in the market are:
- 3billion, Inc.
- Ambry Genetics
- Arup Laboratories
- Artemis DNA
- Centogene N.V.
- Color Genomics, Inc.
- Coopersurgical, Inc.
- Eurofins Scientific
- Fulgent Genetics Inc.
- Genomenon
- Health Network Laboratories
- Invitae Corp.
- Laboratory Corporation of America Holdings
- Macrogen, Inc.
- Myriad Genetics, Inc.
- OPKO Health, Inc.
- PerkinElmer, Inc.
- PreventionGenetics
- Progenity, Inc.
- Quest Diagnostics Inc.
- Realm IDX, Inc.
- Strand Life Sciences
Recent Developments
In February 2022, Bionano Genomics launched the Rare Undiagnosed Genetic Disease (RUGD) initiative to strengthen its focus on clinical and translational research in rare genetic disorders.
In November 2021, Genomenon partnered with Alexion to provide genetic testing laboratories with enhanced data resources to improve the diagnosis of rare diseases.
Table of Contents
Global Rare Disease Genetic Testing Market, by Technology
5.1. Key Findings
5.2. Introduction
5.2.1. Global Rare Disease Genetic Testing Market, by Technology, 2019 – 2032 (USD Million)
5.3. Next-Generation Sequencing
5.3.1. Global Rare Disease Genetic Testing Market, by Next-Generation Sequencing, by Region, 2019 – 2032 (USD Million)
5.3.2. Whole Exome
5.3.2.1. Global Rare Disease Genetic Testing Market, by Whole Exome, by Region, 2019 – 2032 (USD Million)
5.3.3. Whole Genome
5.3.3.1. Global Rare Disease Genetic Testing Market, by Whole Genome, by Region, 2019 – 2032 (USD Million)
5.4. Array Technology
5.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2019 – 2032 (USD Million)
5.5. PCR-based Testing
5.5.1. Global Rare Disease Genetic Testing Market, by PCR-based Testing, by Region, 2019 – 2032 (USD Million)
5.6. FISH
5.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2019 – 2032 (USD Million)
5.7. Sanger Sequencing
5.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2019 – 2032 (USD Million)
5.8. Karyotyping
5.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2019 – 2032 (USD Million)
Global Rare Disease Genetic Testing Market, by Specialty
6.1. Key Findings
6.2. Introduction
6.2.1. Global Rare Disease Genetic Testing Market, by Specialty, 2019 – 2032 (USD Million)
6.3. Molecular Genetic Tests
6.3.1. Global Rare Disease Genetic Testing Market, by Molecular Genetic Tests, by Region, 2019 – 2032 (USD Million)
6.4. Chromosomal Genetic Tests
6.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal Genetic Tests, by Region, 2019 – 2032 (USD Million)
6.5. Biochemical, Genetic Tests
6.5.1. Global Rare Disease Genetic Testing Market, by Biochemical, Genetic Tests, by Region, 2019 – 2032 (USD Million)
Global Rare Disease Genetic Testing Market, by Disease Type
7.1. Key Findings
7.2. Introduction
7.2.1. Global Rare Disease Genetic Testing Market, by Disease Type, 2019 – 2032 (USD Million)
7.3. Neurological Disease
7.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disease, by Region, 2019 – 2032 (USD Million)
7.4. Immunological Disorders
7.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2019 – 2032 (USD Million)
7.5. Hematology Diseases
7.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2019 – 2032 (USD Million)
7.6. Endocrine & Metabolism Diseases
7.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2019 – 2032 (USD Million)
7.7. Cancer
7.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2019 – 2032 (USD Million)
7.8. Musculoskeletal Disorders
7.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2019 – 2032 (USD Million)
7.9. Cardiovascular Disorders
7.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2019 – 2032 (USD Million)
7.10. Dermatology Disease
7.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Disease, by Region, 2019 – 2032 (USD Million)
7.11. Others
7.11.1. Global Other Rare Disease Genetic Testing Market, by Region, 2019 – 2032 (USD Million)
Global Rare Disease Genetic Testing Market, by End-use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Rare Disease Genetic Testing Market, by End-use, 2019 – 2032 (USD Million)
8.3. Research Laboratories & Cros
8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & Cros, by Region, 2019 – 2032 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2019 – 2032 (USD Million)
8.5. Diagnostic Laboratories
8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2019 – 2032 (USD Million)
Regional Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Research Methodology:
The research methodology involves the collection of crucial data and information by expert analysts. The collected data is then carefully filtered to offer an accurate and reliable Rare Disease Genetic Testing market analysis. The primary research technique involves interviews with leading market participants to make it both practical and relevant. Besides, secondary research has been included to provide insights into the demand and supply connection. Publicly available data sources such as annual reports and white papers have also been used to provide an insightful market analysis.
Top Features of Rare Disease Genetic Testing Market Report:
- In-depth market analysis covering all the key market aspects
• Historical, current, and projected market size in terms of value and volume
• Detailed market segmentation covering all the major market segments
• Thorough examination of major market developments
• Assessment of the product offerings of market players and their operating strategies
• Includes classification of potential new clients or partners in the target demographic
Key Questions Answered in Report:
- What are the key market growth drivers?
• What are the market projections considering production value and capacity?
• What will be the impact of strategic developments on market growth?
• Who are the Rare Disease Genetic Testingmarket key players?
• What are the major market trends that can be used to maximize revenue?
• Which research methodologies have been used while prepearing the research report?
• Who could benefit from the research report?
Rare Disease Genetic Testing market research report provides an in-depth analysis by covering all the major market aspects. All the stats and information presented in the study go through a multi-step verification method to ensure accuracy and reliability. The report is a must-read for policymakers, suppliers, stakeholders, and anyone involved or interested in the market.
More Trending Latest Reports By Polaris Market Research: